Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Multicare Pharmaceuticals is a leading branded generics pharmaceutical company based in the Philippines and a prominent subsidiary of the global pharmaceutical major Lupin Limited. Originally established in 1998 as a division of Astra Philippines, the company became an independent entity in 2002 before being acquired by Lupin in 2009. Multicare is currently ranked among the top five branded generic players in the Philippines, maintaining a vast portfolio of over 100 products across therapeutic areas such as diabetes, oncology, gastroenterology, and women's health. The company is actively expanding its presence in the specialty medicine and biosimilars sectors through strategic licensing partnerships with global developers like Alvotech and DKSH. Multicare is recognized for its extensive commercial infrastructure and is a certified Great Place to Work in the Southeast Asian region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Multicare Pharmaceuticals.